STAAR SURGICAL CO (STAA)
2025-06-27 | 2025-03-28 | 2024-09-27 | ||
---|---|---|---|---|
Net sales | 44,320 | 42,589 | 88,590 | |
Cost of sales | 11,521 | 14,584 | 20,103 | |
Gross profit | 32,799 | 28,005 | 68,487 | |
Selling and marketing | 26,283 | 24,621 | 26,623 | |
Restructuring, impairment and related charges | 5,248 | 22,664 | - | |
Research and development | 10,263 | 13,663 | 14,497 | |
General and administrative | 20,969 | 24,458 | 21,685 | |
Total selling, general and administrative expenses | 62,763 | 85,406 | 62,805 | |
Operating income (loss) | -29,964 | -57,401 | 5,682 | |
Other income, net | 120 | 131 | 139 | |
Interest income, net | 1,366 | 1,366 | 1,407 | |
Gain (loss) on foreign currency transactions | 2,563 | 1,418 | 5,931 | |
Total other income (expense), net | 4,049 | 2,915 | 7,477 | |
Income (loss) before income taxes | -25,915 | -54,486 | 13,159 | |
Provision (benefit) for income taxes | -9,103 | -275 | 3,179 | |
Net income (loss) | -16,812 | -54,211 | 9,980 | |
Denominator for basic calculation | 49,520,000 | 49,344,000 | 49,199,000 | |
Earnings per share, basic, total | -0.34 | -1.1 | 0.2 | |
Earnings per share, diluted, total | -0.34 | -1.1 | 0.2 | |
Weighted average number of shares outstanding, diluted, total | 49,520,000 | 49,344,000 | 49,731,000 |